stackArmor, Carahsoft partner with University of Utah School of Medicine to Accelerate FISMA ATO for NEMSIS
StackArmor, Carahsoft partner with University of Utah School of Medicine to Accelerate FISMA ATO for NEMSIS
Source: itnewsonline.com
Data Coordinating News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Data Coordinating. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Data Coordinating Today - Breaking & Trending Today
UPDATE — stackArmor, Carahsoft partner with University of
TYSONS CORNER, Va., Dec. 15, 2023 (GLOBE NEWSWIRE) -- stackArmor, Inc., a leading provider of FedRAMP, FISMA, CMMC 2.0, NIST AI RMF and StateRAMP...
Source: globenewswire.com
Early versus delayed antihypertensive treatment in patients with acute ischaemic stroke: multicentre, open label, randomised, controlled trial
Objectives To compared the effect of early antihypertensive treatment started within 24-48 h of stroke onset versus delaying treatment until day eight on reducing dependency or death. Design Multicentre, randomised, open label trial. Setting 106 hospitals in China between 13 June 2018 and 10 July 2022. Participants 4810 patients (≥40 years) were enrolled with acute ischaemic stroke within 24-48 h of symptom onset and elevated systolic blood pressure between 140 mm Hg and <220 mm Hg. Interventions Patients were randomly assigned to receive antihypertensive treatment immediately after rando...
Source: bmj.com
Medication for Opioid Use Disorder During Pregnancy — Maternal and Infant Network to Understand Outcomes Associated with Use of Medication for Opioid Use Disorder During Pregnancy (MAT-LINK), 2014–2021
This report describes medication for opioid use disorder during pregnancy.
Source: cdc.gov
Daily statin reduces the risk of cardiovascular disease in people living with HIV, large NIH study finds
A National Institutes of Health (NIH) clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale clinical study to test a primary cardiovascular prevention strategy in this population. A planned interim analysis of data from theA National Institutes of Health (NIH) clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale clinical study to tes...
Source: finchannel.com